Skip to content

The deal

Type
Funding
Amount
€255M
Structure
Mostly primary capital alongside a minority transaction in secondary shares
Status
Closed
Round
Round
Post-money
Not recorded
Region
Germany
Date
5 June 2023

As of this development: a later development may record new terms.

Lifecycle

  1. AnnouncedNot recorded
  2. Closed5 June 2023 · This development

Investors in this round

Temasek Holdings · Lead investor

First round with ITM Isotope Technologies Munich

BlackRock · Investor

First round with ITM Isotope Technologies Munich

Qatar Investment Authority · Investor

First round with ITM Isotope Technologies Munich

Nextech · Investor

First round with ITM Isotope Technologies Munich

Athos · Investor

First round with ITM Isotope Technologies Munich

Carbyne · Investor

First round with ITM Isotope Technologies Munich

ITM Isotope Technologies Munich’s rounds

2 rounds since 2023 · ≈ $477M in US$ at each round's date · as disclosed: €443M

ITM Isotope Technologies Munich's funding rounds Minutes has recorded
DateRoundAmountPost-moneyLed byReturning
6 June 2024Funding round€188M≈ US$204M on 6 Jun 2024——5 of 5
5 June 2023Funding round · this round€255M≈ US$273M on 5 Jun 2023—Temasek Holdings0 of 6

Ownership and exit

Acquired by Telix Pharmaceuticals

21 September 2026 · Acquisition · Announced · after 2 rounds since 2023 · The deal

Minutes shows stakes only when a party discloses them.

The parties

ITM Isotope Technologies Munich Issuer

3 developments · 3 deals in Minutes

Temasek Holdings Lead investor

4 developments · 3 deals in Minutes

BlackRock Investor

4 developments · 3 deals in Minutes

Qatar Investment Authority Investor

6 developments · 6 deals in Minutes

More in Healthcare

Past 3 months in Activity →